Summary
CohBar Inc (CohBar) is a biotechnology company that research and develops mitochondria based therapeutics. The company discovers novel mitochondrial-derived peptides. Its MDP portfolio includes MOTS-c for regulation of metabolism and therapeutic potential for Type 2 Diabetes mellitus, obesity, fatty liver and cancers; SHLP-6 targeted at the treatment of cancer; humanin against Alzheimer’s disease, atherosclerosis, myocardial and cerebral ischemia and type 2 diabetes; and SHLP-2 is employed in the treatment of Alzheimer’s disease. CohBar’s expertise comprise cellular and mitochondrial genetics and biology; metabolism; the biology of aging, drug discovery, development and commercialization. The company also conducts scientific research in the fields of age-related diseases, mitochondrial genomics and biology, longevity, metabolism and MDP’s. CohBar is headquartered in Menlo Park, California, the US.
CohBar Inc (COB.U) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CohBar Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CohBar Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CohBar Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CohBar Raises USD0.5 Million in Venture Financing 10
CohBar Raises USD1 Million in Venture Financing 11
Licensing Agreements 12
CohBar Enters into Licensing Agreement with Regents of the University of California 12
CohBar Enters into Licensing Agreement with Regents of the University of California and Albert Einstein College of Medicine 13
Equity Offering 14
CohBar Plans to Raise up to USD18.7 Million in Private Placement of Shares 14
CohBar Raises USD5.2 Million in Private Placement of Units 15
CohBar Raises USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 16
CohBar Raises USD11 Million in IPO of Units 17
CohBar Raises USD2.7 Million in Private Placement of Units 18
CohBar Raises USD2.7 Million in Private Placement of Series B Preferred Stock 19
CohBar Raises USD1.8 Million in Private Placement of Series A Preferred Stock 20
CohBar Raises USD1 Million in Private Placement of Series A Preferred Stock 21
CohBar Raises USD10 Million in Private Placement of Series A Preferred Stock 22
Debt Offering 23
CohBar Raises USD0.07 Million in Private Placement of Convertibles Notes 23
CohBar Inc - Key Competitors 24
CohBar Inc - Key Employees 25
CohBar Inc - Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 14, 2017: CohBar Announces Second Quarter 2017 Financial Results 27
May 15, 2017: CohBar Announces First Quarter 2017 Financial Results 28
Mar 22, 2017: CohBar Announces Fourth Quarter 2016 Financial Results 30
Nov 14, 2016: CohBar Announces Third Quarter 2016 Financial Results 31
Aug 15, 2016: CohBar Announces Second Quarter 2016 Financial Results 32
May 13, 2016: CohBar Announces First Quarter 2016 Financial Results 33
Mar 09, 2016: CohBar Announces Fourth Quarter 2015 Financial Results 34
Corporate Communications 35
Mar 08, 2016: CohBar Appoints Simon Allen as Chief Executive Officer 35
Clinical Trials 36
Apr 11, 2016: CohBar, Inc. Announces Preclinical Proof-of-principle Publication for SHLP Mitochondrial-derived Peptides and their Role in Metabolic Regulation and Cell Viability 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
CohBar Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CohBar Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CohBar Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CohBar Inc, Deals By Therapy Area, 2011 to YTD 2017 8
CohBar Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CohBar Raises USD0.5 Million in Venture Financing 10
CohBar Raises USD1 Million in Venture Financing 11
CohBar Enters into Licensing Agreement with Regents of the University of California 12
CohBar Enters into Licensing Agreement with Regents of the University of California and Albert Einstein College of Medicine 13
CohBar Plans to Raise up to USD18.7 Million in Private Placement of Shares 14
CohBar Raises USD5.2 Million in Private Placement of Units 15
CohBar Raises USD5.3 Million in Private Placement of Shares upon Exercise of Warrants 16
CohBar Raises USD11 Million in IPO of Units 17
CohBar Raises USD2.7 Million in Private Placement of Units 18
CohBar Raises USD2.7 Million in Private Placement of Series B Preferred Stock 19
CohBar Raises USD1.8 Million in Private Placement of Series A Preferred Stock 20
CohBar Raises USD1 Million in Private Placement of Series A Preferred Stock 21
CohBar Raises USD10 Million in Private Placement of Series A Preferred Stock 22
CohBar Raises USD0.07 Million in Private Placement of Convertibles Notes 23
CohBar Inc, Key Competitors 24
CohBar Inc, Key Employees 25
